Elsevier

Nutrition Research

Volume 19, Issue 5, May 1999, Pages 643-649
Nutrition Research

Human study
Efficacy of acacia, pectin, and guar gum-based fiber supplementation in the control of hypercholesterolemia

https://doi.org/10.1016/S0271-5317(99)00029-9Get rights and content

Abstract

We examined the lipid-lowering effects of an acacia, pectin, and guar gum-based product marketed as a fiber supplement, in 50 adults (mean age= 55.4 years) who had an LDL-C ⩾ 4.1 mmol/l (160 mg/dl), or ⩾ 3.4 mmol/l (130 mg/dl) if at least two coronary risk factors were present. All subjects were instructed on a Step I diet not to exceed 30% calories in fat, and half of subjects were randomly assigned to receive 2 packets of the fiber product, containing a total of 9g of fiber. Baseline lipids, medical history, and dietary factors were similar in the two groups. Analysis of covariance adjusted for age, weight change, saturated fat and cholesterol intake, and baseline lipids, demonstrated reductions of 0.4 mmol/l (15.7 mg/dl) in both total (p=0.03) and LDL-cholesterol (p=0.01) after four weeks among those in the fiber supplement group, relative to the diet-only group. A trend of greater lipid reductions and weight loss in the fiber supplement group continued after 12 weeks on the prescribed regimen. Compliance to the prescribed packet count averaged 83% in those completing four weeks (n=21) and 94% in those completing 12 weeks (n=18) on the product. Gastrointestinal discomfort was the most common side effect, documented in 15 (60%) of those initially assigned to the product. Fiber nutrient supplementation with a commercially available acacia, pectin, and guar gum-based product may provide modest short-term benefits in reducing total and LDL-cholesterol, beyond that achieved by a standard cholesterol-lowering diet. The long-term benefits of such products await the conduct of larger, longer-term studies.

References (6)

There are more references available in the full text version of this article.

Cited by (19)

  • Agro waste derived pectin poly and oligosaccharides: Synthesis and functional characterization

    2021, Biocatalysis and Agricultural Biotechnology
    Citation Excerpt :

    Bioconversion of carbohydrate waste is also receiving increased attention in view of the fact that these wastes can act as substrate for the production of useful nutraceuticals, biomaterials and chemical intermediates (Panchami and Gunasekaran, 2017). Health benefits of pectin oligosaccharides (POS), include anti-oxidant, anti-diabetic, anti-obesity, antitumor, anti-cancer, and prebiotic properties as mentioned in Fig. 1 (Hosobuchi et al., 1999; Koriem et al., 2014; Holck et al., 2011; Chen et al., 2017; Kapoor and Dharmesh, 2017; Ogutu et al., 2018). POS derived from different plant materials display bifidogenic effects (Gullon et al., 2013).

  • Cyamopsis tetragonoloba type 1 metallothionein (CtMT1) gene is upregulated under drought stress and its protein product has an additional C-X-C motif and unique metal binding pattern

    2018, International Journal of Biological Macromolecules
    Citation Excerpt :

    Guar gum is a commercial gum used in several industries. In addition, guar gum because of its medicinal uses is an important pharmaceutical product [18,19]. Guar being a legume is a nitrogen-fixing crop and is well known for its tolerance to stresses such as drought, heat and salinity.

  • Phytochemistry, Ethnomedicine, and Pharmacology of Acacia

    2018, Studies in Natural Products Chemistry
    Citation Excerpt :

    Both extracts showed significant diuretic activity but A. nilotica was superior to A. sinuata [313]. Short-term fiber supplementation with a multicomponent herbal product containing Acacia gum produced modest to moderate reduction in total cholesterol and LDL levels in hypercholesteremic human volunteers [314,315]. In contrast, supplementing diet with fiber solely from Acacia gum did not show any significant changes in blood lipid profile in hypercholesterolemic subjects [316–318].

  • Guar gum for body weight reduction: Meta-analysis of randomized trials

    2001, American Journal of Medicine
    Citation Excerpt :

    In 3% of the patients (11 cases) these were severe enough to necessitate the withdrawal from the trial. These findings are corroborated by other reports in the literature (55–57). In addition, possible drug interactions such as a potentiation of the effects of insulin and a decreased absorption of oral contraceptives have been suggested (58).

View all citing articles on Scopus
View full text